.....so ... what's your point ? This was the last decent blockbuster indication partnership deal Mesoblast did and yes it did have a premium attached for the buy in, which was exactly my point and why I posted the information
You don't think SI will command a premium 14 years later with the completion of the phase 3 DREAM-HF trial; the LVAD trial: the HLHS results; the FDA willingness to consider an AA pathway for CHF and of course all of the additional data we have ?
I believe a CHF partnership now will dwarf any previous Mesoblast partnerships but hey that's just my opinion.
MSB $1 Party, page-1123
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
-0.120(9.76%) |
Mkt cap ! $1.267B | |||
| Open | High | Low | Value | Volume |
| $1.20 | $1.20 | $1.11 | $14.06M | 12.25M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 168043 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.12 | 27647 | 1 |
View Market Depth
| Last trade - 16.10pm 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.12 |
Change
-0.120 ( 9.28 %) |
||||
| Open | High | Low | Volume | ||
| $1.20 | $1.20 | $1.12 | 1823761 | ||
| Last updated 15.59pm 30/05/2024 ? | |||||
| MSB (ASX) Chart |